High Court Won't Mull Punitives In Drug Labeling Suits
The U.S. Supreme Court declined Monday to consider Novartis Pharmaceutical Corp.'s contention that federal law preempts the awarding of punitive damages for the legal marketing of prescription drugs, keeping in place...To view the full article, register now.
Already a subscriber? Click here to view full article